Classificação em ações
#10096
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated... Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Preço da ação
$19.81
Última sincronização: 2026-08-28
Valor de mercado
$891.32M
Negociar Beta Bionics, Inc. (BBNX)
Preço BBNX com a capitalização de mercado de B
Capitalização de mercado de Beta Bionics, Inc.(BBNX)
Valor de mercado: $891.32M
Em August 2026, Beta Bionics, Inc. tem uma capitalização de mercado de $891.32M. Isso faz com que Beta Bionics, Inc. seja a 10096th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Beta Bionics, Inc. de 2025 a 2026
BBNX comparado com o topo de 5 mais populares stocks
| Preço para BBNX |
|
Ativo B |
Capitalização de mercado de B |
Resultados |
|
|
|
|
$5.264T
|
+590,468.44%
|
|
|
|
|
$4.701T
|
+527,349.64%
|
|
|
|
|
$4.177T
|
+468,549.57%
|
|
|
|
|
$3.817T
|
+428,185.19%
|
|
|
|
|
$2.866T
|
+321,482.56%
|
